Bionomics Limited

Australian and New Zealand biotech investors are set to hear from a top line up of speakers from ASX-listed life science companies, as well as several private firms and international businesses, in July, at the 11th Bioshares Biotech Summit.

Bionomics Limited (ASX: BNO) - 2007 Annual General Meeting - Dr Peter Jonson, Chairman and Dr Deborah Rathjen, CEO and MD; Bionomics Limited (ASX: BNO) present the following audio webcast regarding "2007 Annual General Meeting".

Bionomics Limited (ASX: BNO) - Bionomics Raises $10 Million in Private Placement - Dr Deborah Rathjen, CEO and MD; Boardroomradio is pleased to announce that Bionomics Limited (ASX: BNO) has published an audio file.

Bionomics Limited (ASX: BNO) - New Drug Candidate for Anxiety - Dr Deborah Rathjen, CEO and MD; Boardroomradio is pleased to announce that Bionomics Limited (ASX: BNO) has published an audio file.

Bionomics Limited (ASX: BNO) - Annual General Meeting - Dr Deborah Rathjen, CEO & MD; Boardroomradio is pleased to announce that Bionomics Limited (ASX: BNO) has published an audio file.

Bionomics Limited (ASX: BNO) - Contract with SAFC Pharma - Dr Deborah Rathjen, CEO & MD; Boardroomradio is pleased to announce that Bionomics Limited (ASX: BNO) has published an audio file.

BIONOMICS LIMITED (ASX: BNO) - The New Bionomics - Dr Deborah Rathjen, CEO; Boardroomradio is pleased to announce that BIONOMICS LIMITED (ASX: BNO) has published an audio file.

BIONOMICS LIMITED (ASX: BNO) - Market Briefing - Dr Deborah Rathjen, CEO; Boardroomradio is pleased to announce that BIONOMICS LIMITED (ASX: BNO) has published an audio file. The following presentatio

Bionomics (ASX:BNO, BNOOA, BNOOB, US OTC:BMICY) today announced that it has been granted a patent in New Zealand for a series of compounds that have shown promise as potential new treatments for cancer.